An interdisciplinary team of researchers from The
University of Manchester have developed a new graphene-based
testing system for disease-related antibodies, initially targeting
a kidney disease called Membranous Nephropathy.
An interdisciplinary team of researchers from The
University of Manchester have developed a new graphene-based
testing system for disease-related antibodies, initially targeting
a kidney disease called Membranous Nephropathy.